AI MARKET SCANNING

Intensity Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -1.14%
MAX GAP RECORD -9.56%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INTS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN)
-2.80%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+1.17%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+1.03%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+7.14%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-3.09%
Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE)
-8.39%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
-2.00%
Aug 08, 2024 Earnings Release 2024-08-08 (AFTER CLOSE)
+1.73%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.7%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INTS

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗